EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 2, 2025

Primary Completion Date

November 2, 2025

Study Completion Date

August 2, 2026

Conditions
Sleep QualityStress Reduction
Interventions
DEVICE

Treatment with BTL-699-2

Six transcranial magnetic stimulation treatments with the BTL-699-2 device will be delivered over the left dorsolateral prefrontal cortex, spaced 3 to 7 days apart. The intensity will be adjusted according to the subject's feedback, up to 70% of the individual's motor threshold.

DEVICE

Treatment with BTL-699-2 (sham)

Six transcranial magnetic stimulation treatments with the BTL-699-2 device will be delivered over the left dorsolateral prefrontal cortex, spaced 3 to 7 days apart. The intensity will be adjusted according to the subject's feedback, up to 5% of the individual's motor threshold.

Trial Locations (3)

60447

RECRUITING

Minooka Healthcare Center, Minooka

91914

RECRUITING

AntiAging and Wellness, Chula Vista

92024

RECRUITING

Kind Health Group, Encinitas

All Listed Sponsors
lead

BTL Industries Ltd.

INDUSTRY